系统性红斑狼疮的全面疾病控制:单中心队列与机器学习分析
该单中心纵向研究纳入172例随访5年的SLE患者,评估以缓解且无慢性损伤进展定义的LupusCDC频率。结果显示含完全缓解的LupusCDC在各时间点最常见,仅5.8%患者全程维持;未达该状态与肾脏受累及免疫抑制剂/糖皮质激素使用相关,机器学习模型有一定预测能力。
要点
- LupusCDC定义为缓解≥1年且前1年无慢性损伤进展
- 仅5.8%患者5年全程维持LupusCDC,从未有肾脏受累
- 未达LupusCDC与肾脏受累及免疫抑制剂/GC使用显著相关
核心结论
- 单中心队列数据提示LupusCDC可将SLE疾病活动性与慢性损伤合并为一个结局,便于全面评估患者。
研究设计与样本
- 单中心纵向分析纳入172例SLE患者,要求随访5年且每年至少一次访视。
- 疾病活动性用SLEDAI-2K评估,慢性损伤用SLICC损伤指数(SDI)评估。
- 采用非线性支持向量机(SVM)与决策树(DT)建模,并用ReliefF算法进行特征排序。
主要发现
- 随访期间SDI值(基线均值±SD 0.7±1.1)显著增加。
- 所有分析时间点中,含完全缓解(CR)的LupusCDC最常被检出。
- 未达到LupusCDC与肾脏受累及免疫抑制剂和糖皮质激素(GC)使用显著相关。
- 维持LupusCDC者GC使用比例显著更低(p=0.0001)。
关键数值与推荐
- LupusCDC定义为缓解至少1年且此前1年无慢性损伤进展。
- 评估了三种缓解水平:完全缓解(CR)、停用糖皮质激素的临床缓解、使用糖皮质激素的临床缓解。
- 机器学习模型预测性能:DT的AUC为0.703±0.02,SVM的AUC为0.713±0.02。
临床怎么用
- 可将LupusCDC作为综合评估SLE疾病活动性与慢性损伤的复合结局指标。
- 对肾脏受累或需免疫抑制剂/糖皮质激素治疗的患者,应关注其达到LupusCDC的难度。
局限性
- 研究为单中心队列,结论需外部验证。
- 机器学习模型AUC约0.70,预测能力有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We evaluated a monocentric SLE cohort in order to assess the frequency of Lupus comprehensive disease control (LupusCDC), a condition defined by the achievement of remission and the absence of damage progression. METHODS: Our longitudinal analysis included SLE patients with 5-years follow-up and at least one visit per year. Disease activity was assessed by SLE Disease Activity Index 2000 (SLEDAI-2K) and three different remission levels were evaluated (Complete Remission, CR; Clinical remission off-corticosteroids; clinical remission on-corticosteroids). Chronic damage was assessed according to SLICC Damage Index (SDI). LupusCDC was defined as remission achievement for at least one year plus absence of chronic damage progression in the previous one year. A machine learning based analysis was carried out, applying and comparing Nonlinear Support Vector Machines (SVM) models and Decision Trees (DT), whereas features ranking was performed with the ReliefF algorithm. RESULTS: We evaluated 172 patients [M/F 16/156, median age 49 years (IQR 16.7), median disease duration 180 months (IQR 156)]. SDI values (baseline mean±SD 0.7 ± 1.1) significantly increased during the follow-up period. In all time-points analyzed, LupusCDC including CR was the most frequently detected. The failure to reach this condition was significantly associated with renal involvement and with the intake of immunosuppressant drugs and glucocorticoid (GC). Ten patients (5.8%) have maintained LupusCDC during the whole 5-year follow-up: these patients had never presented renal involvement and showed lower prevalence of anti-phospholipid antibodies (p = 0.0001). Finally, the prevalence of GC intake was significantly lower (p = 0.0001). The application of machine learning models showed that the available features were able to provide significant information to build predictive models with an AUC score of 0.703 ± 0.02 for DT and 0.713 ± 0.02 for SVM. CONCLUSIONS: Our data on a monocentric cohort suggest that the LupusCDC can efficaciously merge into one outcome SLE-related disease activity and chronic damage in order to perform an all-around evaluation of SLE patients.
引用
- Ceccarelli F, Olivieri G, Sortino A, et al. Comprehensive disease control in systemic lupus erythematosus. Semin Arthritis Rheum. 2021. PMID: 33652293. doi:10.1016/j.semarthrit.2021.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。